Healthcare Triangle is trading 6.2% up in pre-market at $0.84, with no new company-specific catalyst identified for September 8, 2026.
- The latest notable announcement was September 3’s planned separation of Teyame AI Holdings and minority-share dividend for Healthcare Triangle shareholders.
- The plan remains subject to SEC review and Nasdaq approval.
- The release does not explicitly attribute today’s movement to the plan; broader sentiment is cautious, leaving the pre-market gain unexplained.